Heidelberg Pharma AG

Share Issue/Capital Change • Nov 10, 2006

News Details

Ad-hoc | 10 November 2006 07:13

WILEX shares successfully placed at EUR 13.80

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Ad–hoc announcement according to § 15 WpHG WILEX shares successfully placed at EUR 13.80 Munich, November 10, 2006 – The Munich-based biopharmaceutical company WILEX AG (ISIN DE0006614720; WKN 661472), together with WestLB AG, Düsseldorf and Sal. Oppenheim jr. & Cie. Kommanditgesellschaft auf Aktien, Köln, today announced the placing price of its offered shares as well as additional details regarding the allotment of shares. The offering price has been fixed at EUR 13.80 per share. 4.6 million shares including an over-allotment option (greenshoe) were placed in the offering. 4,000,000 shares result from a capital increase resolved by the ordinary shareholders’ meeting on September 11, 2006. The 600,000 shares for the over-allotment option were lent by an existing shareholder through a share loan agreement. Should the over-allotment option be exercised, the executive management board, with the approval of the supervisory board, will resolve the issuance of the appropriate number of ordinary bearer shares through a capital increase from authorised capital. The shares were placed with institutional investors throughout Europe. As part of the placement existing shareholders HDP Beteiligungs GmbH (HDP) and Funds managed by TVM Capital GmbH (TVM) subscribed to and were allotted shares in addition to those shares already held before the offering. The number of shares held by HDP will increase from 2,041,953 shares to 3,411,953 shares. HDP’s holding will be 28.5% without exercise of the Greenshoe option and 27.2% if the Greenshoe is exercised in full. The number of shares held by TVM will increase from 853,355 shares to 925,819 shares. TVM’s holding will be 7.7% without exercise of the Greenshoe option and 7.4% if the Greenshoe is exercised in full. The shares subscribed by and allotted to the above mentioned investors in the offering will not be subject to the lock-up agreements signed by existing shareholders regarding shares held before the offering. Including the shares subscribed for and allotted to HDP and TVM the free float of the company will be approximately 36.6%. Private investors were not allotted any shares. The issue volume is approximately EUR 63.5 million including the over-allotment shares. The company raised approximately EUR 55.2 million from the capital increase of 4 million shares (before transaction costs). In case of a complete exercise of the over-allotment option the company will raise an additional EUR 8.3 million (before transaction costs). Trading is expected to begin on November 13, 2006 in the Prime-Standard of the regulated market of the Frankfurt stock exchange. Contact Juliane Giese Manager Public Relations WILEX AG Grillparzerstr. 16 81675 Munich Germany Tel.: +49 (0)89-41 31 38-29 Fax: +49 (0)89-41 31 38-99 Email: juliane.giese@wilex.com Please note: This document constitutes neither an offer to sell nor a solicitation to buy securities of WILEX AG. The securities have already been sold. This document is not an offer to buy securities in the United States of America. Securities may only be sold or offered for purchase in the United States of America with prior registration subject to the provisions of the US Securities Act 1933 in the currently-valid version, or in the absence of prior registration, only on the basis of an exception. Shares in WILEX AG are not and will not be registered pursuant to the provisions of the US Securities Act 1933 in the currently-valid version, and will neither be sold nor offered for purchase in the United States of America. The information contained in this document is not intended to be passed on into the USA or within the USA. This document is directed at and/or for distribution in the U. K. only to (i) persons who have professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the ‘Order’) or (ii) high net worth entities falling within article 49(2)(a) to (d) of the Order (all such persons being together referred to as ‘relevant persons’). This document is directed only at relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons. (c)DGAP 10.11.2006 ————————————————————————— Language: English Issuer: WILEX AG Grillparzerstr. 16 81675 München Deutschland Phone: +49 (0)89 41 31 38 – 0 Fax: +49 (0)89 41 31 38 – 99 E-mail: info@wilex.com WWW: www.wilex.de ISIN: DE0006614720 WKN: 661472 Indices: Listed: Amtlicher Markt in Frankfurt (Prime Standard) Notierung vorgesehen / designated to be listed End of News DGAP News-Service —————————————————————————